a higher-BMI subgroup reached 30.3% at 104 weeks
In the analysis, the researchers assessed the outcomes of 26 randomized controlled trials comprising 15,491 participants with overweight or obesity
In the SURMOUNT-1 trial, which evaluated tirzepatide for chronic weight management in adults without diabetes, approximately 67% of participants were women
"I feel like, after having my kids, my body was missing something
Yes every batch ships with a batch-specific COA documenting HPLC purity and mass-spectrometry identity
DPP-4 inhibitors are also used therapeutically to enhance endogenous GLP-1 activity, but only for glycemic control, as they are weight-neutral